Kensey Nash Corporation traces its beginnings to 1984 with its
first two employees being co-founders John Nash and Kenneth Kensey,
M.D. Since then, the Company has expanded to more than 300 employees
with a management team that represents some of the most experienced
professionals in the industry.
Executive
Officers
|
Joseph W. Kaufmann
President and CEO
With KNC since 1989
|
Douglas G. Evans, P.E.
Chief Operating Officer
With KNC since 1989 |
Michael Celano, C.P.A.
Chief Financial Officer
With KNC since 2009
|
John E. Nash, P.E.
Vice President of
New Technology
Co-Founder and former
Executive Vice President
With KNC since 1984
|
Todd M. DeWitt
Vice President of
Biomaterials
With KNC since 1988 |
James (Ted) Rauth, P.E.
Vice President of
Operations
With KNC since 1999 |
Russell T. Kronengold, Ph.D.
Vice President of
Biomaterials Research
With KNC since 1997
|
|
|
Senior Management |
Donald L. Daveler
Vice President of
Quality Assurance/
Quality Control
With KNC since 1990
|
Gregory A. Walters
Vice President of Product
Development
With KNC since 1992
|
Thomas M. Maguire
Vice President of Clinical
and Regulatory
With KNC since 2008
|
Jeffrey C. Kelly, ESQ.
Vice President of Legal Affairs
With KNC since 2000
|
|
|
|
|
|
Overview